Vivos Therapeutics, Inc. (NASDAQ:VVOS) Sees Large Decline in Short Interest

Vivos Therapeutics, Inc. (NASDAQ:VVOS) saw a large drop in short interest in the month of March. As of March 15th, there was short interest totalling 249,000 shares, a drop of 27.6% from the February 28th total of 344,000 shares. Based on an average daily volume of 210,600 shares, the days-to-cover ratio is presently 1.2 days. Currently, 5.4% of the shares of the company are sold short.

Vivos Therapeutics Stock Down 2.5 %

VVOS stock opened at $3.11 on Monday. The business’s 50-day moving average price is $3.78 and its 200-day moving average price is $3.61. The stock has a market cap of $18.32 million, a P/E ratio of -0.55 and a beta of 7.47. Vivos Therapeutics has a twelve month low of $1.91 and a twelve month high of $6.28.

Hedge Funds Weigh In On Vivos Therapeutics

Hedge funds have recently made changes to their positions in the business. Cutter & CO Brokerage Inc. purchased a new position in Vivos Therapeutics in the 4th quarter worth approximately $163,000. Commonwealth Equity Services LLC raised its position in shares of Vivos Therapeutics by 23.8% during the fourth quarter. Commonwealth Equity Services LLC now owns 26,000 shares of the company’s stock valued at $112,000 after buying an additional 5,000 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Vivos Therapeutics by 55.6% in the fourth quarter. Geode Capital Management LLC now owns 44,827 shares of the company’s stock worth $192,000 after buying an additional 16,025 shares in the last quarter. Finally, Anson Funds Management LP bought a new position in shares of Vivos Therapeutics during the fourth quarter worth $1,041,000. Institutional investors own 26.35% of the company’s stock.

About Vivos Therapeutics

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.